Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1996 3
1997 3
1998 4
2000 5
2001 5
2002 2
2003 6
2004 7
2005 14
2006 12
2007 12
2008 13
2009 8
2010 8
2011 7
2012 9
2013 3
2014 6
2015 5
2016 3
2017 3
2018 1
2019 1
2021 3
2022 1
2023 3
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors.
Nishimura T, Velaga R, Masuda N, Kawaguchi K, Kawaguchi S, Takada M, Maeshima Y, Tanaka S, Kikawa Y, Kadoya T, Bando H, Nakamura R, Yamamoto Y, Ueno T, Yasojima H, Ishiguro H, Morita S, Ohno S, Haga H, Matsuda F, Ogawa S, Toi M. Nishimura T, et al. Among authors: maeshima y. Cancer Sci. 2024 Dec;115(12):3928-3942. doi: 10.1111/cas.16339. Epub 2024 Oct 7. Cancer Sci. 2024. PMID: 39375938 Free PMC article.
Antiangiogenic Therapy for Diabetic Nephropathy.
Tanabe K, Maeshima Y, Sato Y, Wada J. Tanabe K, et al. Among authors: maeshima y. Biomed Res Int. 2017;2017:5724069. doi: 10.1155/2017/5724069. Epub 2017 Aug 1. Biomed Res Int. 2017. PMID: 28835895 Free PMC article. Review.
Antisense oligonucleotides.
Kashihara N, Maeshima Y, Makino H. Kashihara N, et al. Among authors: maeshima y. Exp Nephrol. 1998 Jan-Feb;6(1):84-8. doi: 10.1159/000020509. Exp Nephrol. 1998. PMID: 9523178 Review.
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Saldajeno DP, Kawaoka S, Masuda N, Tanaka S, Bando H, Nishimura T, Kadoya T, Yamanaka T, Imoto S, Velaga RM, Tamura N, Aruga T, Ikeda K, Fukui Y, Maeshima Y, Takada M, Suzuki E, Ueno T, Ogawa S, Haga H, Ohno S, Morita S, Kawaguchi K, Toi M. Saldajeno DP, et al. Among authors: maeshima y. Br J Cancer. 2024 Apr;130(6):1023-1035. doi: 10.1038/s41416-023-02527-0. Epub 2024 Jan 18. Br J Cancer. 2024. PMID: 38238427
Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169+ macrophages by metastatic breast cancers.
Maeshima Y, Kataoka TR, Vandenbon A, Hirata M, Takeuchi Y, Suzuki Y, Fukui Y, Kawashima M, Takada M, Ibi Y, Haga H, Morita S, Toi M, Kawaoka S, Kawaguchi K. Maeshima Y, et al. EBioMedicine. 2024 Sep;107:105271. doi: 10.1016/j.ebiom.2024.105271. Epub 2024 Aug 21. EBioMedicine. 2024. PMID: 39173531 Free PMC article.
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.
Yamaguchi A, Kawaguchi K, Kawanishi K, Maeshima Y, Nakakura A, Kataoka TR, Takahara S, Nakagawa S, Yonezawa A, Takada M, Kawashima M, Kawaguchi-Sakita N, Kotake T, Suzuki E, Shimizu H, Torii M, Morita S, Ishiguro H, Toi M. Yamaguchi A, et al. Among authors: maeshima y. Breast Cancer Res Treat. 2024 Apr;204(2):261-275. doi: 10.1007/s10549-023-07163-z. Epub 2023 Dec 21. Breast Cancer Res Treat. 2024. PMID: 38123790 Free PMC article.
Molecular mechanism of cell injury.
Maeshima Y, Makino H. Maeshima Y, et al. Contrib Nephrol. 2003;139:32-43. doi: 10.1159/000071735. Contrib Nephrol. 2003. PMID: 12854317 Review. No abstract available.
144 results